Molecular Design

Controlling the behavior of compounds and materials by manipulation of molecular properties.

Monday, 20 August 2012

QSAR: Nailed to its perch?

›
I must confess that I’ve never been a big fan of QSAR. When I started in Pharma 24 years ago, QSAR was seen as as something that would sol...
5 comments:
Thursday, 9 August 2012

Lipophilicity and Pharmacological Promiscuity

›
We often hear and read that pharmacological promiscuity is strongly correlated with lipophilicity and it's often a good idea to check th...
Sunday, 29 July 2012

Imidazole lipophilicity revisited

›
It's almost three months since I arrived in Brasil to spend year in São Carlos at Universidade de São Paulo. One of the advantages of b...
3 comments:
Saturday, 26 May 2012

How not to do FBDD?

›
It’s not often that bloggers get responses from the authors of the articles that they’ve featured and it’s much rarer still for a re...
Tuesday, 20 March 2012

Scoring non-additivity

›
Getting the most from target-ligand interactions is the essence of structure-based design and many of us believe that fragment-based methods...
5 comments:
Saturday, 4 February 2012

JCAMD 25th Anniversary Issue

›
The editors of the Journal of Computer-Aided Molecular Design commissioned a number of Perspectives on the state and future of the field to...
Friday, 3 February 2012

Fragment lead identification by SPR

›
FBDD is a maturing field and one sign this maturation is the publication of a volume of Methods in Enzymology devoted to the subject. The...
‹
›
Home
View web version

Contributors

  • Mel
  • Peter Kenny
Powered by Blogger.